14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
EHTH vs QDEL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over QuidelOrtho Corporation (QDEL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHTH carries a Unified Composite Score of 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin), whereas QDEL carries 44.2/100 (HOLD) at $9.96 (7.8x Forward P/E, 0.2% operating margin).
Composite vs. Pillar Nuance: While QDEL currently prints a higher short-term Unified Composite Score (44.2/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 0.2% operating margin) and revenue trajectory (-60.5% vs. -11.6% YoY).
Technical & Structure Timing Caution: EHTH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile QDEL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EHTH vs QDEL. Trailing 12-month operating profitability (EHTH 11.9% vs QDEL 0.2%) and valuation multiples (EHTH 0.2x vs QDEL 7.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $736.9M market capitalization and 0.2% operating margin.
OpEx & R&D Reinvestment44.3% of Rev ($1.15B)
90D Engineering Disclosures0 Published
Investor FAQ EHTH vs QDEL Key Questions & Quantitative Answers
As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over QuidelOrtho Corporation (QDEL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHTH carries a Unified Composite Score of 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin), whereas QDEL carries 44.2/100 (HOLD) at $9.96 (7.8x Forward P/E, 0.2% operating margin). Composite vs. Pillar Nuance: While QDEL currently prints a higher short-term Unified Composite Score (44.2/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 0.2% operating margin) and revenue trajectory (-60.5% vs. -11.6% YoY). Technical & Structure Timing Caution: EHTH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile QDEL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
QDEL leads the Growth & Scale pillar: EHTH posts -60.5% YoY revenue growth and -17.6% YoY earnings growth on $469M TTM revenue (100.0% gross margin, 11.9% operating margin), compared with QDEL at -11.6% YoY revenue growth and -77.1% YoY earnings growth on $2.59B TTM revenue (44.5% gross margin, 0.2% operating margin). On trailing 12-month operating scale, EHTH generates $469M in USD-normalized revenue versus $2.59B for QDEL. In operating R&D and SG&A reinvestment, EHTH deploys N/A (0 90-day corporate R&D disclosures) versus 44.3% of Rev ($1.15B) (0 disclosures) for QDEL.
EHTH screens cheaper on headline valuation multiples. EHTH trades at 0.2x Forward P/E, 0.2x Trailing P/E, 0.72x PEG, and N/M EV/Revenue (12.4% EBITDA margin), whereas QDEL trades at 7.8x Forward P/E, 9.6x Trailing P/E, 2.06x PEG, and 1.4x EV/Revenue (-4.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHTH (2.6% ROE) versus QDEL (-19.3% ROE) capital efficiency.
In options market volatility and institutional positioning, EHTH carries 128.7% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 117% Vol realized risk). By comparison, QDEL carries 101.3% implied volatility (23rd %ile, Compressed (<25th %ile)), a 2.41x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.72β · 106% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.